Search results
Nuno Cortez-Dias
Job title: Cardiology Fellow
Author
Immune Cell Traits and Heart Failure: A Mendelian Randomisation Study
Author(s):
Wei Gao
,
Hui Wang
,
Jian-long Wang
,
et al
Added:
5 months ago
Original Research
Author(s):
Michael R Zile
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Zile (Medical University of South Carolina, US) to discuss the outcomes of the RELIEVE-HF trial.RELIEVE-HF is designed to evaluate the safety and effectiveness of the V-Wave interatrial shunt system in patients with heart failure. 605 participants with New York Heart Association (NYHA) functional class II, class III or class IV heart failure, who had…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
A prespecified secondary analysis of the DAN-RSV trial has found that a bivalent respiratory syncytial virus (RSV) vaccine is similarly effective against respiratory and cardiovascular outcomes in older adults, regardless of pre-existing atherosclerotic cardiovascular disease (ASCVD).¹The bivalent RSV prefusion F protein-based (RSVpreF) vaccine contains stabilised prefusion F glycoproteins from…
View more
Frederick Raal
Job title: Professor and Director of the Carbohydrate and Lipid Metabolism Research Unit
Author
John GF Cleland
Research Area(s) / Expertise:
Author
Expertise
Heart FailureCardiovascular Kidney MetabolicCardiomyopathies and Cardiac AmyloidosisHeart Failure ComorbiditiesGuidelines & StatementsChronic Heart Failure ManagementPrevention & Chronic ConditionsChronic Kidney DiseaseHeart Failure Services, Prevention and Digital HealthObesityImaging & DiagnosticsHeart Failure Diagnosis and ImagingCardiomyopathiesHeart Failure in WomenCardiovascular Co-MorbiditiesPeripheral Artery Disease - GeneralSymptom and Congestion ManagementVascular Disease and SurgeryMedication Optimisation and TitrationMI/ACSHeart Failure and Iron DeficiencyHeart Failure DevicesDemographicDiabetesElectrophysiology & ArrhythmiaEchocardiography & UltrasoundGenderHypertensionAtrial FibrillationEquity, Age, Sex, and ReproductionMetabolic dysfunction-associated fatty liver disease (MAFLD)
Erika SW Jones
Job title: Nephrology and Hypertension Specialist
Author
Author(s):
Camilla Andersen
Added:
7 months ago
EASD Congress 2025 - Dr Camilla Andersen (The University of Western Australia, Perth, AU) joins us to discuss findings from the EMPIRE-PREVENT: Metabolic study, investigating the metabolic effects of empagliflozin in elderly and obese patients at high risk of developing heart failure (HF).This randomized controlled trial evaluated 165 patients aged 60–84 years with obesity (BMI >28kg/m²) and…
View more
Gerry O'Sullivan
Job title: Clinical Director of Radiology
Author
Yogesh Reddy
Research Area(s) / Expertise:
Author
Expertise
Heart FailureCardiovascular Kidney MetabolicCardiomyopathies and Cardiac AmyloidosisHeart Failure ComorbiditiesGuidelines & StatementsChronic Heart Failure ManagementPrevention & Chronic ConditionsChronic Kidney DiseaseHeart Failure Services, Prevention and Digital HealthObesityImaging & DiagnosticsHeart Failure Diagnosis and ImagingCardiomyopathiesHeart Failure in WomenCardiovascular Co-MorbiditiesPeripheral Artery Disease - GeneralSymptom and Congestion ManagementVascular Disease and SurgeryMedication Optimisation and TitrationMI/ACSHeart Failure and Iron DeficiencyHeart Failure DevicesDemographicDiabetesElectrophysiology & ArrhythmiaEchocardiography & UltrasoundGenderHypertensionAtrial FibrillationEquity, Age, Sex, and ReproductionMetabolic dysfunction-associated fatty liver disease (MAFLD)